Home › Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

US Patent 11753627 · Granted Sep 12, 2023

Assignee

The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

Inventors

Stephen S. Whitehead (48 patents)
Brian R. Murphy (80 patents)
Lewis Markoff (9 patents)
Barry Falgout (7 patents)
Joseph E. Blaney (31 patents)
Kathryn A. Hanley (17 patents)
Ching-Juh Lai (29 patents)

View full patent text on Google Patents →